Zombie Unicorns Haunt Silicon Valley: The Dramatic Fall of Once-Hyped Billion-Dollar Startups

Silicon Valley has long been home to mythical creatures of the startup world: unicorns (valued at over $1 billion), decacorns ($10 billion+), and even rarer hectocorns. But according to a recent Economist article, a new and far less glamorous beast has emerged — the "zombie unicorn."

These are companies that once commanded sky-high valuations during the frothy funding environment of the early 2020s, only to see their worth plummet dramatically. Today, they linger in a half-alive state: still operating, but stripped of their former glory, often struggling to raise fresh capital or achieve meaningful growth. Their primary survival strategy? Chasing the next big hype wave — frequently anything related to artificial intelligence.

The Boom Years: Easy Money and Sky-High Hype

Just five years ago, in the wake of the pandemic and amid historically low interest rates, capital flowed freely into tech startups. Investors competed aggressively to back promising (and sometimes not-so-promising) ideas. Luxurious offices opened in San Francisco and beyond, complete with perks that signaled success. Analysts and media outlets breathlessly declared these companies the future of their industries — from consumer apps to health tech.

Valuations soared on the back of rapid user growth, pandemic-driven demand shifts, and optimistic projections. Many companies achieved unicorn status seemingly overnight, fueled by rounds led by prominent venture firms and even SoftBank’s Vision Fund in some cases.

The Harsh Reality: Valuations Crater 10-20x or More

Zombie Unicorns Haunt Silicon Valley: The Dramatic Fall of Once-Hyped Billion-Dollar Startups The party ended as interest rates rose sharply starting in 2022. Fundraising dried up significantly — dropping to around $66 billion last year in some reports — and investors became far more discerning. Companies that had been valued based on hype rather than sustainable fundamentals faced brutal markdowns.

By mid-2026, data from Stanford professor Ilya Strebulaev’s unicorn database showed that out of roughly 1,900 tracked unicorns globally, 332 had raised money at valuations at or below their previous peaks.

Of those, 212 were now valued below $1 billion. Hundreds had gone years without new funding rounds, and dozens had officially lost their unicorn status.

The result is a cohort of "zombies" — firms that exist more out of inertia and the hope of catching a new narrative than because of strong current performance or clear paths to profitability and exits for investors.

Cameo: A Textbook Case of the Zombie Unicorn

One of the most striking examples highlighted in coverage of this trend is Cameo, the platform that lets fans book personalized video messages from celebrities, athletes, and influencers.

Zombie Unicorns Haunt Silicon Valley: The Dramatic Fall of Once-Hyped Billion-Dollar Startups In 2021, amid a surge in demand for virtual entertainment during lockdowns, Cameo raised a massive round and hit a $1 billion valuation. It was a darling of the moment — fun, scalable in theory, and riding the creator economy wave.

Fast forward to today: its valuation has collapsed to around $82 million — a drop of more than 90%. The company has undergone significant downsizing, faced regulatory issues (including difficulty paying fines in the past), and seen revenue decline sharply from its pandemic peak.

Cameo still operates and attempts to adapt — exploring new features or adjacent opportunities — but its primary existence now revolves around surviving rather than thriving or scaling aggressively. It exemplifies how even seemingly straightforward consumer apps can be wildly overvalued when growth metrics are extrapolated without sufficient scrutiny of unit economics or long-term demand.

Broader Examples and the AI Lifeline

Zombie Unicorns Haunt Silicon Valley: The Dramatic Fall of Once-Hyped Billion-Dollar Startups Cameo is far from alone. Another frequently cited case is SonderMind, a mental health platform that connects patients with therapists.

It reached unicorn status in 2021 with a valuation well north of $1 billion (some reports cited figures around $1.1–1.56 billion post-money).

Its value has since reportedly fallen to as low as $7 million in recent assessments.

Many of these zombie unicorns are now desperately trying to rebrand or pivot toward AI-related features or applications to attract fresh interest from investors still pouring money into anything generative AI-adjacent.

While genuine AI innovation is creating new unicorns and excitement, it also serves as a convenient narrative life raft for older companies whose core businesses have stagnated.

Implications for Silicon Valley and Venture Capital

Zombie Unicorns Haunt Silicon Valley: The Dramatic Fall of Once-Hyped Billion-Dollar Startups This epidemic of zombie unicorns is more than just a collection of sad stories — it reflects deeper structural issues in the venture ecosystem. Venture capitalists are sitting on portfolios filled with markdowns, which hurts returns for newer funds and makes limited partners more cautious. Liquidity events (IPOs or acquisitions) remain rare for many of these companies, trapping capital and talent.

The phenomenon also serves as a cautionary tale about valuation discipline. During boom times, narrative and momentum can override fundamentals. When the music stops, the gap between hype and reality becomes painfully clear.

While Silicon Valley continues to generate genuine breakthroughs — especially in AI — the lingering presence of these diminished giants serves as a reminder of past excesses. The zombies may not disappear overnight, but they highlight the need for more sustainable growth models, realistic valuations, and a focus on building enduring businesses rather than chasing the next unicorn stamp.

As the Economist notes, it will take more than a new hype cycle to fully revive them. For now, they continue to haunt the Valley — shadows of their former billion-dollar selves.